UF
REGN icon

Univest Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Univest Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.15M Sell
13,072
-1,134
-8% -$772K 0.4% 51
2026
Q1 		$11M Sell
14,206
-5,194
-27% -$3.98M 0.62% 40
2025
Q4 		$15M Sell
19,400
-923
-5% -$627K 0.79% 27
2025
Q3 		$11.4M Sell
20,323
-223
-1% -$126K 0.64% 39
2025
Q2 		$10.8M Buy
20,546
+2,127
+12% +$1.19M 0.65% 40
2025
Q1 		$11.7M Buy
18,419
+4,217
+30% +$2.9M 0.76% 30
2024
Q4 		$10.1M Sell
14,202
-1,514
-10% -$1.27M 0.64% 42
2024
Q3 		$16.5M Buy
15,716
+10,024
+176% +$11.2M 1.09% 25
2024
Q2 		$5.98M Sell
5,692
-158
-3% -$153K 1.66% 17
2024
Q1 		$5.63M Sell
5,850
-1,159
-17% -$1.1M 1.58% 21
2023
Q4 		$6.16M Sell
7,009
-115
-2% -$94.7K 1.82% 16
2023
Q3 		$5.86M Buy
7,124
+448
+7% +$352K 1.96% 12
2023
Q2 		$4.8M Sell
6,676
-474
-7% -$365K 1.45% 22
2023
Q1 		$5.87M Buy
7,150
+2,107
+42% +$1.59M 1.83% 15
2022
Q4 		$3.64M Sell
5,043
-998
-17% -$736K 1.15% 33
2022
Q3 		$4.16M Buy
+6,041
New +$3.8M 1.36% 22

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Univest Financial's REGN Position: Q2 2026 in Review

Univest Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 8% in Q2 2026, selling an estimated $772K and leaving 13,072 shares worth $8.15M. The position accounts for 0.4% of the portfolio, ranked #51.

Univest Financial first reported a position in REGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $16.5M in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Univest Financial held 13,072 shares of Regeneron Pharmaceuticals worth $8.15M as of Q2 2026.
  • Univest Financial sold 1,134 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $772K.
  • Regeneron Pharmaceuticals made up 0.4% of Univest Financial's portfolio in Q2 2026, its #51 holding.
  • Univest Financial first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Univest Financial's Regeneron Pharmaceuticals position peaked at $16.5M in Q3 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Univest Financial's 13F filing for Q2 2026, filed 7 Aug 2026.